Chongqing Imperial Now GMP for Chondroitin

CHONGQING, China—Chongqing Imperial Bio-Chem Co. Ltd. announced it is now producing its chondroitin sulfate under GMP (good manufacturing practice) standards, and that it received approval from the China Food and Drug Administration (China SDA) to produce chondroitin sulfate EP5.5 for pharmaceutical (98 to 102 percent by CPC) and nutraceutical (85 percent and USP29) products.

For more information, visit www.canimperial.com or Booth #1012 at SupplySide West.